Table 1

Oligonucleotide primers used in this study

Gene/fragment location (bp)MethodForward sequence (5′ to 3′)Reverse sequence (5′ to 3′)
−371-FLAP promoter HRE-M1 (−170 to −167) SDM gtgtgctggctttgcaggctcctctgccaag cttggcagaggagcctgcaaagccagcacac 
−371-FLAP promoter HRE-M2 (−251 to −248) SDM gcctgtgctgggctcaggctggtcatggtc gaccatgaccagcctgagcccagcacaggc 
−371-FLAP promoter NFκB-M1 (−43 to −34) SDM ggcactgtgtaattgtgccgaggctctgcagaaattgtaatg cattacaatttctgcagagcctcggcacaattacacagtgcc 
−371-FLAP promoter NFκB-M2 (−43 to −34) SDM ggcactgtgtaattgtgccgggaagcgtcagaaattgtaatg cattacaatttctgacgcttcccggcacaattacacagtgcc 
HRE (−170 to −167) in FLAP promoter EMSA ctggctttgcgtgctcctctg cagaggagcacgcaaagccag 
HRE mutant in FLAP promoter EMSA ctggctttgaaagctcctctg cagaggagctttcaaagccag 
FLAP promoter (−310/+9) ChIP cagagatgatggcagcttcca aaggggaagtgagagcttgca 
Gene/fragment location (bp)MethodForward sequence (5′ to 3′)Reverse sequence (5′ to 3′)
−371-FLAP promoter HRE-M1 (−170 to −167) SDM gtgtgctggctttgcaggctcctctgccaag cttggcagaggagcctgcaaagccagcacac 
−371-FLAP promoter HRE-M2 (−251 to −248) SDM gcctgtgctgggctcaggctggtcatggtc gaccatgaccagcctgagcccagcacaggc 
−371-FLAP promoter NFκB-M1 (−43 to −34) SDM ggcactgtgtaattgtgccgaggctctgcagaaattgtaatg cattacaatttctgcagagcctcggcacaattacacagtgcc 
−371-FLAP promoter NFκB-M2 (−43 to −34) SDM ggcactgtgtaattgtgccgggaagcgtcagaaattgtaatg cattacaatttctgacgcttcccggcacaattacacagtgcc 
HRE (−170 to −167) in FLAP promoter EMSA ctggctttgcgtgctcctctg cagaggagcacgcaaagccag 
HRE mutant in FLAP promoter EMSA ctggctttgaaagctcctctg cagaggagctttcaaagccag 
FLAP promoter (−310/+9) ChIP cagagatgatggcagcttcca aaggggaagtgagagcttgca 

ChIP indicates chromatin immunoprecipitation; EMSA, electrophoretic mobility shift assay; PCR, polymerase chain reaction; and SDM, site-directed mutagenesis. The specific mutations are highlighted in bold type.

or Create an Account

Close Modal
Close Modal